Norton Healthcare providing Bamlanivimab for COVID-19 patients at risk of hospitalization
Norton Healthcare is making monoclonal antibody treatment Bamlanivimab available under the Food and Drug Administration’s emergency use authorization for certain patients at high risk for requiring hospitalization for COVID-19. We are fortunate to have extensive […]
View moreAll Norton Healthcare providers now can order convalescent plasma for severe or critical COVID-19 patients
Under an emergency use authorization by the Food and Drug Administration (FDA), all Norton Healthcare providers can order convalescent plasma therapy for confirmed COVID-19 hospitalized patients with severe or critical symptoms. Norton Healthcare hospitals have […]
View moreNorton Healthcare to offer COVID-19 Long-term Care Clinic for patients with lasting side effects
Norton Healthcare will launch a COVID-19 Long-term Care Clinic for adult patients who continue to experience side effects after having battled the coronavirus. “Norton Healthcare has been a regional leader in caring for patients with […]
View moreCritically ill COVID-19 patients who received convalescent plasma leaving hospital
More than 30 critically ill COVID-19 patients at Norton Healthcare have received convalescent plasma, an experimental treatment that began in mid-April. Some are still recovering, while many patients have been able to go home. Norton […]
View moreNew algorithm available for C. difficile testing
Effective Monday, Sept. 9, Norton Healthcare replaced the algorithm for C. difficile testing with a new approach designed to provide clinicians greater clarity regarding the significance of a positive result. The new algorithm will begin […]
View moreSepsis information for providers
Define sepsis Systemic inflammatory response syndrome (SIRS) criteria Temperature > 38.3 C (> 100.9 F) Temperature < 36.0 C (< 96.8 F) Heart rate > 90 Respiratory rate > 20 White blood cell >12,000 or […]
View moreUpdates in hepatitis C treatment eligibility
Norton Healthcare treats all patients with chronic hepatitis C regardless of F score or sobriety. Here’s what providers should know. Many factors can affect the plan of care to treat hepatitis C, including genotype of […]
View moreNorton Complex Care Clinic opens new location in Corydon
Norton Healthcare launched the Norton Complex Care Clinic in Louisville to treat patients with hepatitis C. A new location is now open in Corydon, Indiana to bring expertise and educational resources to patients in the […]
View moreActive pulmonary tuberculosis cases on the rise
The number of active pulmonary tuberculosis cases has increased in Louisville Metro recently. Symptoms of pulmonary tuberculosis include a chronic cough lasting more than two weeks, fever, night sweats and unintended weight loss. In the […]
View moreNorton Healthcare’s response to hepatitis A outbreak
Norton Healthcare is working to combat Louisville’s hepatitis A outbreak by making vaccinations available to employees and vaccinating high-risk patients in our Emergency Departments. “This is a little out of the ordinary. We don’t normally […]
View moreNorton Infectious Disease specialist leads presentation on LGBTQ health
Paul S. Schulz, M.D. with Norton Infectious Disease Specialists led a Norton Healthcare system-wide presentation last month on the staggering statistics related to the health of LGBTQ individuals, in an effort to continuously educate providers […]
View moreInfectious Disease specialists available through Norton Healthcare
Norton Infectious Disease specialists are committed to providing quality health care. All of the specialists in the practice are specially trained in infectious diseases. The physicians also provide inpatient and outpatient care at Norton Brownsboro […]
View more